APO RESEARCH · REPORT
Tuberculosis (TB) Detection
Tuberculosis (TB) is a chronic infection caused by the bacterium tuberculosis (TB).Tuberculous bacterium invades human body all sorts of organs possibly, but basically encroach lung, call tuberculosis disease.
Product & engineering
Understand the product.
Tuberculosis (TB) is a chronic infection caused by the bacterium tuberculosis (TB).Tuberculous bacterium invades human body all sorts of organs possibly, but basically encroach lung, call tuberculosis disease.
Tuberculosis (TB) is a chronic and slow - onset infectious disease in young people.The incubation period is 4 to 8 weeks.Of these, 80% occur in the lungs, and other areas (cervical lymph, meninges, peritoneum, intestine, skin, bone) may also be secondary to infection.Transmission of respiratory tract from person to person is the main mode of transmission.Infection source is the person that contacts the tuberculosis that discharges bacterium.With the spread of environmental pollution and AIDS, the incidence of TB is becoming more and more intense.In addition to a few cases of rapid onset, clinical more chronic process.There are often low fever, fatigue and other systemic symptoms and respiratory symptoms such as cough, hemoptysis.
Selected research
Market Structure
Global Tuberculosis (TB) Detection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Tuberculosis (TB) is a chronic infection caused by the bacterium tuberculosis (TB).Tuberculous bacterium invades human body all sorts of organs possibly, but basically encroach lung, call tuberculosis disease.
Tuberculosis (TB) is a chronic and slow - onset infectious disease in young people.The incubation period is 4 to 8 weeks.Of these, 80% occur in the lungs, and other areas (cervical lymph, meninges, peritoneum, intestine, skin, bone) may also be secondary to infection.Transmission of respiratory tract from person to person is the main mode of transmission.Infection source is the person that contacts the tuberculosis that discharges bacterium.With the spread of environmental pollution and AIDS, the incidence of TB is becoming more and more intense.In addition to a few cases of rapid onset, clinical more chronic process.There are often low fever, fatigue and other systemic symptoms and respiratory symptoms such as cough, hemoptysis.
In Southeast Asia, Tuberculosis (TB) Detection key players include Danaher, Roche, Thermal Fisher, Abbott, etc.
Read the full market overview
Indonesia is the largest market, with a share over 20%, followed by Philippines, and Myanmar, both have a share about 30 percent.
In terms of product, Bacterial Culture Test is the largest segment, with a share about 50%. And in terms of application, the largest application is Hospital, followed by Clinic, Research Institution, etc.
Report Includes
This report provides an overview of the global Tuberculosis (TB) Detection market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Tuberculosis (TB) Detection and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Tuberculosis (TB) Detection revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Tuberculosis (TB) Detection market size, projected growth trends, production technologies, key applications, and end-use industries.
Tuberculosis (TB) Detection Segment by Company
Danaher
Roche
Thermal Fisher
Abbott
Oxford Immunotec International
Qiagen
Hologic
Hain Lifescience
Epistem
Creative Diagnostics
Tuberculosis (TB) Detection Segment by Type
Bacterial Culture Test
Tuberculin Test
Rapid Molecular Diagnosis
Other
Tuberculosis (TB) Detection Segment by Application
Hospital
Clinic
Research Institution
Other
Tuberculosis (TB) Detection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis (TB) Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis (TB) Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis (TB) Detection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Tuberculosis (TB) Detection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tuberculosis (TB) Detection industry.
Chapter 3: Detailed analysis of Tuberculosis (TB) Detection companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tuberculosis (TB) Detectionrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Bacterial Culture Test
- Tuberculin Test
- Rapid Molecular Diagnosis
- Other
Applications
- Hospital
- Clinic
- Research Institution
- Other
Companies covered
- Danaher
- Roche
- Thermal Fisher
- Abbott
- Oxford Immunotec International
- Qiagen
- Hologic
- Hain Lifescience
- Epistem
- Creative Diagnostics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Tuberculosis (TB) Detection Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Bacterial Culture Test
- 1.2.3 Tuberculin Test
- 1.2.4 Rapid Molecular Diagnosis
- 1.2.5 Other
- 1.3 Market Analysis by Application
- 1.3.1 Global Tuberculosis (TB) Detection Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Research Institution
- 1.3.5 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Tuberculosis (TB) Detection Growth Trends by Region
- 1.5.1 Global Tuberculosis (TB) Detection Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Tuberculosis (TB) Detection Market Size by Region (2021-2026)
- 1.5.3 Tuberculosis (TB) Detection Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Tuberculosis (TB) Detection Market Dynamics
- 2.1 Tuberculosis (TB) Detection Industry Trends
- 2.2 Tuberculosis (TB) Detection Industry Drivers
- 2.3 Tuberculosis (TB) Detection Industry Opportunities and Challenges
- 2.4 Tuberculosis (TB) Detection Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Tuberculosis (TB) Detection Revenue by Company (2021-2026)
- 3.2 Global Tuberculosis (TB) Detection Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Tuberculosis (TB) Detection Key Company Head office and Area Served
- 3.4 Global Tuberculosis (TB) Detection Company, Product Type & Application
- 3.5 Global Tuberculosis (TB) Detection Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Tuberculosis (TB) Detection Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Tuberculosis (TB) Detection Players Market Share by Revenue in 2025
- 3.6.3 2025 Tuberculosis (TB) Detection Tier 1, Tier 2, and Tier 3
4 Tuberculosis (TB) Detection Market by Type
- 4.1 Global Tuberculosis (TB) Detection Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Tuberculosis (TB) Detection Market Size by Type (2021-2032)
- 4.3 Global Tuberculosis (TB) Detection Market Size Share by Type (2021-2032)
5 Tuberculosis (TB) Detection Market by Application
- 5.1 Global Tuberculosis (TB) Detection Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Tuberculosis (TB) Detection Market Size by Application (2021-2032)
- 5.3 Global Tuberculosis (TB) Detection Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Danaher
- 6.1.1 Danaher Company Information
- 6.1.2 Danaher Business Overview
- 6.1.3 Danaher Tuberculosis (TB) Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Danaher Tuberculosis (TB) Detection Product Portfolio
- 6.1.5 Danaher Recent Developments
- 6.2 Roche
- 6.2.1 Roche Company Information
- 6.2.2 Roche Business Overview
- 6.2.3 Roche Tuberculosis (TB) Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Roche Tuberculosis (TB) Detection Product Portfolio
- 6.2.5 Roche Recent Developments
- 6.3 Thermal Fisher
- 6.3.1 Thermal Fisher Company Information
- 6.3.2 Thermal Fisher Business Overview
- 6.3.3 Thermal Fisher Tuberculosis (TB) Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Thermal Fisher Tuberculosis (TB) Detection Product Portfolio
- 6.3.5 Thermal Fisher Recent Developments
- 6.4 Abbott
- 6.4.1 Abbott Company Information
- 6.4.2 Abbott Business Overview
- 6.4.3 Abbott Tuberculosis (TB) Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Abbott Tuberculosis (TB) Detection Product Portfolio
- 6.4.5 Abbott Recent Developments
- 6.5 Oxford Immunotec International
- 6.5.1 Oxford Immunotec International Company Information
- 6.5.2 Oxford Immunotec International Business Overview
- 6.5.3 Oxford Immunotec International Tuberculosis (TB) Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Oxford Immunotec International Tuberculosis (TB) Detection Product Portfolio
- 6.5.5 Oxford Immunotec International Recent Developments
- 6.6 Qiagen
- 6.6.1 Qiagen Company Information
- 6.6.2 Qiagen Business Overview
- 6.6.3 Qiagen Tuberculosis (TB) Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Qiagen Tuberculosis (TB) Detection Product Portfolio
- 6.6.5 Qiagen Recent Developments
- 6.7 Hologic
- 6.7.1 Hologic Company Information
- 6.7.2 Hologic Business Overview
- 6.7.3 Hologic Tuberculosis (TB) Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Hologic Tuberculosis (TB) Detection Product Portfolio
- 6.7.5 Hologic Recent Developments
- 6.8 Hain Lifescience
- 6.8.1 Hain Lifescience Company Information
- 6.8.2 Hain Lifescience Business Overview
- 6.8.3 Hain Lifescience Tuberculosis (TB) Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Hain Lifescience Tuberculosis (TB) Detection Product Portfolio
- 6.8.5 Hain Lifescience Recent Developments
- 6.9 Epistem
- 6.9.1 Epistem Company Information
- 6.9.2 Epistem Business Overview
- 6.9.3 Epistem Tuberculosis (TB) Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Epistem Tuberculosis (TB) Detection Product Portfolio
- 6.9.5 Epistem Recent Developments
- 6.10 Creative Diagnostics
- 6.10.1 Creative Diagnostics Company Information
- 6.10.2 Creative Diagnostics Business Overview
- 6.10.3 Creative Diagnostics Tuberculosis (TB) Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Creative Diagnostics Tuberculosis (TB) Detection Product Portfolio
- 6.10.5 Creative Diagnostics Recent Developments
7 North America
- 7.1 North America Tuberculosis (TB) Detection Market Size (2021-2032)
- 7.2 North America Tuberculosis (TB) Detection Market Size by Type
- 7.2.1 North America Tuberculosis (TB) Detection Market Size by Type (2021-2026)
- 7.2.2 North America Tuberculosis (TB) Detection Market Size by Type (2027-2032)
- 7.2.3 North America Tuberculosis (TB) Detection Market Share by Type (2021-2032)
- 7.3 North America Tuberculosis (TB) Detection Market Size by Application
- 7.3.1 North America Tuberculosis (TB) Detection Market Size by Application (2021-2026)
- 7.3.2 North America Tuberculosis (TB) Detection Market Size by Application (2027-2032)
- 7.3.3 North America Tuberculosis (TB) Detection Market Share by Application (2021-2032)
- 7.4 North America Tuberculosis (TB) Detection Market Size by Country
- 7.4.1 North America Tuberculosis (TB) Detection Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Tuberculosis (TB) Detection Market Size by Country (2021-2026)
- 7.4.3 North America Tuberculosis (TB) Detection Market Size by Country (2027-2032)
- 7.4.4 North America Tuberculosis (TB) Detection Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Tuberculosis (TB) Detection Market Size (2021-2032)
- 8.2 Europe Tuberculosis (TB) Detection Market Size by Type
- 8.2.1 Europe Tuberculosis (TB) Detection Market Size by Type (2021-2026)
- 8.2.2 Europe Tuberculosis (TB) Detection Market Size by Type (2027-2032)
- 8.2.3 Europe Tuberculosis (TB) Detection Market Share by Type (2021-2032)
- 8.3 Europe Tuberculosis (TB) Detection Market Size by Application
- 8.3.1 Europe Tuberculosis (TB) Detection Market Size by Application (2021-2026)
- 8.3.2 Europe Tuberculosis (TB) Detection Market Size by Application (2027-2032)
- 8.3.3 Europe Tuberculosis (TB) Detection Market Share by Application (2021-2032)
- 8.4 Europe Tuberculosis (TB) Detection Market Size by Country
- 8.4.1 Europe Tuberculosis (TB) Detection Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Tuberculosis (TB) Detection Market Size by Country (2021-2026)
- 8.4.3 Europe Tuberculosis (TB) Detection Market Size by Country (2027-2032)
- 8.4.4 Europe Tuberculosis (TB) Detection Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Tuberculosis (TB) Detection Market Size (2021-2032)
- 9.2 China Tuberculosis (TB) Detection Market Size by Type
- 9.2.1 China Tuberculosis (TB) Detection Market Size by Type (2021-2026)
- 9.2.2 China Tuberculosis (TB) Detection Market Size by Type (2027-2032)
- 9.2.3 China Tuberculosis (TB) Detection Market Share by Type (2021-2032)
- 9.3 China Tuberculosis (TB) Detection Market Size by Application
- 9.3.1 China Tuberculosis (TB) Detection Market Size by Application (2021-2026)
- 9.3.2 China Tuberculosis (TB) Detection Market Size by Application (2027-2032)
- 9.3.3 China Tuberculosis (TB) Detection Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Tuberculosis (TB) Detection Market Size (2021-2032)
- 10.2 Asia Tuberculosis (TB) Detection Market Size by Type
- 10.2.1 Asia Tuberculosis (TB) Detection Market Size by Type (2021-2026)
- 10.2.2 Asia Tuberculosis (TB) Detection Market Size by Type (2027-2032)
- 10.2.3 Asia Tuberculosis (TB) Detection Market Share by Type (2021-2032)
- 10.3 Asia Tuberculosis (TB) Detection Market Size by Application
- 10.3.1 Asia Tuberculosis (TB) Detection Market Size by Application (2021-2026)
- 10.3.2 Asia Tuberculosis (TB) Detection Market Size by Application (2027-2032)
- 10.3.3 Asia Tuberculosis (TB) Detection Market Share by Application (2021-2032)
- 10.4 Asia Tuberculosis (TB) Detection Market Size by Country
- 10.4.1 Asia Tuberculosis (TB) Detection Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Tuberculosis (TB) Detection Market Size by Country (2021-2026)
- 10.4.3 Asia Tuberculosis (TB) Detection Market Size by Country (2027-2032)
- 10.4.4 Asia Tuberculosis (TB) Detection Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Tuberculosis (TB) Detection Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Tuberculosis (TB) Detection Market Size by Type
- 11.2.1 South America, Middle East & Africa Tuberculosis (TB) Detection Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Tuberculosis (TB) Detection Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Tuberculosis (TB) Detection Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Tuberculosis (TB) Detection Market Size by Application
- 11.3.1 South America, Middle East & Africa Tuberculosis (TB) Detection Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Tuberculosis (TB) Detection Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Tuberculosis (TB) Detection Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Tuberculosis (TB) Detection Market Size by Country
- 11.4.1 South America, Middle East & Africa Tuberculosis (TB) Detection Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Tuberculosis (TB) Detection Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Tuberculosis (TB) Detection Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Tuberculosis (TB) Detection Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst